Viewing Study NCT00916032


Ignite Creation Date: 2025-12-24 @ 9:47 PM
Ignite Modification Date: 2026-01-31 @ 8:41 PM
Study NCT ID: NCT00916032
Status: COMPLETED
Last Update Posted: 2021-05-19
First Post: 2009-06-05
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Pharmacokinetic Study of ADVATE 3000 IU in Previously Treated Patients With Severe Hemophilia A
Sponsor: Baxalta now part of Shire
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 060801
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators